JSC made an announcement on the 6th that it signed a memorandum of understanding (MOU) with Bundang Seoul National University Hospital on research, development, clinical application and commercialization in the bio-health industry using VR, AR and MR.
Under the agreement, the two sides agreed to work together to develop ideas for technologies that can be applied VR, AR, and MR in the field of healthcare and to find research for the development of medical convergence contents such as diagnosis, treatment, surgery, education, and training related to VRVR, AR, MR application of clinical trials
▲ and to commercialize medical convergence contents jointly R&D, demonstration, technology transfer, and service.
Since 2016, JS has been working with various medical departments and joint projects with Bundang Seoul National University Hospital, including VR hands-on treatment solutions for children's patients, VR walking rehabilitation training systems, VR solutions for improving vision of low vision patients, VR dizziness rehabilitation training and dry eye patient management mobile apps.
In particular, the agreement is expected to accelerate the acquisition of medical licenses for the results of the VR hands-on explanation prescription study for children's patients, commercialization of hospital care services for actual patients using VR and overseas exports.
Oh Chang-wan, research vice president of Bundang Seoul National University Hospital, said, "VR and AR are areas that can be applied in various fields such as patient treatment and medical staff education. Through solid cooperation between J.S. and Bundang Seoul National University Hospital, it is expected to further enhance the happiness and health of patients and help them take the lead in smart hospitals for future healthcare innovation."
Lee Se-hwan, director of JSC, said, "We are happy to have a closer cooperative relationship with Bundang Seoul National University Hospital, which has the world's best ICT infrastructure with excellent medical staff. We will do our best to create content that gives joy to both medical staff and patients through expanded research that combines advanced ICT such as 5G and AI with VR and AR technologies that we have accumulated so far."
Meanwhile, JS is determined to make full-fledged inroads into the medical market in the Middle East, and to become a global company specializing in realistic content beyond game companies through commercialization of the defense and education sectors as well as the medical sector.
JSC made an announcement on the 6th that it signed a memorandum of understanding (MOU) with Bundang Seoul National University Hospital on research, development, clinical application and commercialization in the bio-health industry using VR, AR and MR.
Under the agreement, the two sides agreed to work together to develop ideas for technologies that can be applied VR, AR, and MR in the field of healthcare and to find research for the development of medical convergence contents such as diagnosis, treatment, surgery, education, and training related to VRVR, AR, MR application of clinical trials
▲ and to commercialize medical convergence contents jointly R&D, demonstration, technology transfer, and service.
Since 2016, JS has been working with various medical departments and joint projects with Bundang Seoul National University Hospital, including VR hands-on treatment solutions for children's patients, VR walking rehabilitation training systems, VR solutions for improving vision of low vision patients, VR dizziness rehabilitation training and dry eye patient management mobile apps.
In particular, the agreement is expected to accelerate the acquisition of medical licenses for the results of the VR hands-on explanation prescription study for children's patients, commercialization of hospital care services for actual patients using VR and overseas exports.
Oh Chang-wan, research vice president of Bundang Seoul National University Hospital, said, "VR and AR are areas that can be applied in various fields such as patient treatment and medical staff education. Through solid cooperation between J.S. and Bundang Seoul National University Hospital, it is expected to further enhance the happiness and health of patients and help them take the lead in smart hospitals for future healthcare innovation."
Lee Se-hwan, director of JSC, said, "We are happy to have a closer cooperative relationship with Bundang Seoul National University Hospital, which has the world's best ICT infrastructure with excellent medical staff. We will do our best to create content that gives joy to both medical staff and patients through expanded research that combines advanced ICT such as 5G and AI with VR and AR technologies that we have accumulated so far."
Meanwhile, JS is determined to make full-fledged inroads into the medical market in the Middle East, and to become a global company specializing in realistic content beyond game companies through commercialization of the defense and education sectors as well as the medical sector.